Clinical outcome after anti-tumour necrosis factor therapy discontinuation in 1000 patients with inflammatory bowel disease: the EVODIS long-term study

Volume: 53, Issue: 12, Pages: 1277 - 1288
Published: May 7, 2021
Abstract
Background null The long-term outcome of patients after antitumour necrosis factor alpha (anti-TNF) discontinuation is not well known. null Aims null To assess the risk of relapse in the long-term after anti-TNF discontinuation. null Methods null This was an extension of the evolution after anti-TNF discontinuation in patients with inflammatory bowel disease (EVODIS) study (Crohn's disease or ulcerative colitis patients treated with anti-TNFs in...
Paper Details
Title
Clinical outcome after anti-tumour necrosis factor therapy discontinuation in 1000 patients with inflammatory bowel disease: the EVODIS long-term study
Published Date
May 7, 2021
Volume
53
Issue
12
Pages
1277 - 1288
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.